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Is migraine with cranial nerve palsy an 
ophthalmoplegic migraine?







and the Observatoire des
Migraines et Céphalées of the
French Headache Society
Abstract Ophthalmoplegic
migraine (OM) is a rare form of
primary headache. Because of its
rarity, only a few cases, mostly
symptomatic, are reported. We
analyse nine cases among 52 973
adults who suffer from headaches
with an oculomotor palsy firstly
considered as OM. The study was
retrospective and multicentric in a
database set up in France. The aim
of our investigation was to
describe the clinical and radiologi-
cal aspects of these cases and to
discuss the diagnosis of OM. We
demonstrate that the characteristics
of the headaches were identical to
usual migraine without oculomotor
nerve palsy for each case. The
study emphasises the difficulty of
the OM diagnosis even with the
new IHS criteria because of the
rarity of having all characateris-
tics. A wide heterogeneity was
noted in cranial imagery and blood
tests. We suggest adding the code
of probable OM in the IHS classi-
fication to increase the knowledge
and detection of this type of
headache. A biological blood test
and an MRI are systematically
required to help clinicians in their
diagnosis and to exclude alterna-
tive aetiology of headache with
palsy.
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Introduction
Ophthalmoplegic migraine (OM) was first described by
Gubler in 1860 according to Pearce [1]. First considered as
a clinical form of migraine, the second edition of the
International Headache Disorders (ICHD II) classifies the
disease as a cranial neuralgia and a central cause of facial
pain, code 13-17 [2]. OM remains a rare disorder, with a
prevalence, probably less than one case in a million [3]. In
adults, this diagnosis is exceptional, because all alternative
causes of painful oculomotor nerve palsy must first be
excluded. To date, most of the reported cases are paediatric
or even young adults [4]. The pathophysiology of the dis-
ease remains unknown. Recently, publications with cranial
MRI depict the presence of contrast enhancement of the
oculomotor nerve in the peri-cerebral region that is con-
sidered by authors as a specific sign [5]. However, this sign
does not seem to be systematically present and thus was
not included in the ICHD II criteria. In a retrospective
study, we have identified nine cases of migraine with oph-
thalmoplegia belonging to the Observatoire des Migraines
et Céphalées French database.
The aim of our study was to describe these cases and to
discuss the concept and its limits in clinical practice.
Patients and methods
The French database (Observatoire des Migraines et Céphalées)
is a French collaborative database set up by the French Headache
Society (Société Française d’Etudes des Migraines et des
Cephalées) in 2002. The database contains all headache patients
who have consulted in 13 tertiary headache centres in France
(Annecy, Bordeaux, Clermont-Ferrand, Colombes, Lille,
Marseille, Nice, Paris, Toulouse, Tours, Rouen, Saint Etienne,
Voiron) since October 2002. It is an adult database because no
paediatric consultations are included in the project. All patients
were classified in accordance with the ICHD I and secondly with
the ICHD II criteria. On principle, when the disease was rare and
even if all criteria were not present, the subject was included as
a possible OM. This methodology was proposed to facilitate fur-
ther study. With this method, we identified all patients with a
diagnosis of OM included in the database from October 2002 to
December 2005. The personal and family histories of headaches
as well as clinical data from each case were collected. When
available, the results of biological blood tests and brain imagery
were collected. 
Results 
Among 52 973 cases collected in the database, there were
nine patients with OM diagnosis: six women and three
males with an average age of 36 (16–74). The main data
are summarised in Table 1. All cases suffered from
migraine with (2) or without aura (7) that began before the
first OM attack. Migraine was present in 60% of the fami-
lies but in two cases this information was not available.
OM had appeared either during childhood (1) or during
adulthood (8). Headaches were present in seven cases
before and during ophthalmoplegia (2 cases). The time
between pain and ophthalmoplegia was variable (no time
in two cases to 4 days). The description of the headaches
was not different from usual migraine. Unilateral or frontal
pulsating pain was systematically described. Its location
was on the same side as the palsy. Attacks of ophthalmo-
plegia with pain were present only once in two cases
whereas in seven cases several attacks were noted (two to
more than four). The cranial nerve most commonly affect-
ed was the third one (55%) but several times the palsy
affected different nerves of the same patient (the third and
the sixth nerve, 2 cases). In two cases, a diplopic sensation
was described but no cranial nerve palsy was observed. In
all cases, the general and neurological examination was
always normal outside attacks. Biological blood test was
very heterogeneous with wide exploration searching for
diabetes mellitus, myasthenia or inflammatory disease in
four cases. A brain CT-scan (one case) or MRI (seven
cases) with digitalised angiography was performed except
in one case. Brain CT-scan or MRI imagery was done once
in seven cases. A single case had three CT-scans. The result
was always normal or revealed no specific abnormalities
such as abnormal white matter signals. No contrast
enhancement was identified on cranial nerve but the delay
between palsy and MRI was unknown in most cases. In no
case was conventional angiography carried out. For the
single case where no brain imagery was done, the repeti-
tion of attacks had first suggested a non-tumoral cause, but
the patient was not followed up. Prophylactic or acute
treatment was not systematically given and was varied as
described in Table 1. The cranial palsy and headache was
always reversible in a few weeks. The follow up was vari-
able among centres. Two cases were lost to follow-up, and
only one case presented another attack after inclusion in
the database.
Discussion
This French retrospective multicentric study has identified
nine cases of adults suffering from migraine with oculo-
motor nerve palsy in 3 years among 52 973 headache
patients seen in 13 tertiary centres. As the study is retro-
spective and multicentric, there is a heterogeneity in par-
aclinical examinations. However, the rarity of the OM
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observed is in accordance with previous work that under-
lines that OM is exceptional in the general population [4].
For instance, the prevalence of OM in Scandinavia was of
0.7 per million in a previous study in the general popula-
tion [3]. On the contrary, Donahue reported 14% of
diplopia among 1600 cases of migraine sufferers [6]. This
high prevalence of an ophthalmic symptom was never
demonstrated in other studies. The discrepancy among
studies can be explained by the limited size of the
Donahue study [6].
Several data of OM are underlined in our work even
though it is more complex to analyse data from a retro-
spective analysis than a prospective study. On clinical
grounds, we can insist on several aspects of the disease
found routinely. Firstly, OM remains a diagnosis of exclu-
sion in clinical practice even if the ICHD II proposes sev-
eral strict criteria to identify the disease [2]. These criteria
are mainly based on clinical signs and repetition of the
attacks without abnormality in paraclinical examinations.
In ICHD II, headache is described as migraine-like but in
most published cases, the description is non-existent or
poor [4–7]. In fact, in our cases the description of pain
does not appear different in type, localisation or intensity
from usual migraine attacks. Therefore, this work demon-
strates that pain in OM is very similar to other migraine
attacks without ophthalmoplegia. Secondly, by definition,
headaches accompany or follow within the 4 days of its
onset by paralysis of one or more of the third, fourth and
sixth cranial nerves. Østergaard et al. [8] reported a single
unusual case where four attacks of ophthalmoplegia were
present without headache in a baby. Unilateral headache
was present only at the fifth episode at the age of three.
This exceptional case puts forward the question of accept-
able time between palsy and pain. In order to improve the
distinction between OM and other causes of nerve palsy,
ICHD II proposes a maximum time of 4 days between the
two signs [2]. This time, in light of our work, is helpful in
clinical practice because all cases are in accordance with
this criterion. In two of our cases headache appeared
simultaneously with cranial palsy, as reported by Lance
and Zagani [7]. In these cases, the clinical signs as well as
the spontaneous good evolution without corticosteroid
rule out the diagnosis of Tolosa-Hunt syndrome. Thirdly,
repetition of cranial nerve palsy is necessary for the defi-
nite diagnosis of OM. Two of our cases have had only one
episode of cranial nerve palsy with migraine headache and
should theoretically not be classified as OM in ICHD II.
The duration of the follow-up for these two cases was one
and two years. No recurrence was observed. As no alter-
native aetiologies were present, they were coded as OM.
Because the situation is also not exceptional, IHS classifi-
cation would offer the possibility to code them as proba-
ble OM. Probable OM could be proposed as probable
migraine in cases where attacks and/or headache without
one of the features needed to fulfil all criteria for OM.
This possibility would improve the detection of OM.
Fourthly, the oculomotor nerve is mostly implicated in
OM [3, 4, 7, 8]. However, this nerve is concerned in
44%–66% in acute ocular mononeuropathy in the general
population. Periorbital pain is also almost systematically
depicted whatever the cause in this situation [9, 10]. A
microvascular ischaemia of the pericerebral portion of the
nerve is frequently suspected, explaining both signs but
other causes such as a viral infection or a metabolic abnor-
mality is possible. In OM, the pathophysiological mecha-
nism remains debated but our work brings no information
Table 1 Main data of the ophtalmoplegic migrainer
Case Age (years), Ophtalmoplegic migraine CT-Scan MRI Angiography Treatment Evolution,
sex Duration of follow-up
Number Time between Cranial
of attacks headache Nerve
and palsy 
1 74, F 3 4 days III R, III, VI N N N No NR, 3 years
2 48, F 1 Unknown VI L ND N N Oxetorone NR, 1 year
3 16, F 1 Unknown III L N N N Not specify NR, 2 years
4 16, M 3 2 III N N N Not specify NR, 2 years
5 54, M 2 5 VI R, VI L N N N Oxetorone NR, 4 years
6 23, F 4 No delay III L ND ND ND NSAiDS Lost sight 
7 29, M >5 30 min diplopia N N N Oxetorone, NR, 1 year
8 24, F 2 No delay diplopia ND N N Not specify Lost sight 
9 48, F 4 No delay III L ND N N NSAiDS R, 1 year
F, female; M, male; III, oculomotor nerve; VI, abducens nerve; N, normal; ND, not done; L, left; R, right; NR, no recurrence; R, recurrence
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on this aspect because it is an observational study. The
main hypothesis is that OM is due to a demyelinating neu-
ropathy [7]. This hypothesis is supported by the presence
of a contrast enhancement and a thickening of the ocular
nerve in its cisternal portion detected by MRI that was not
observed in our cases [4, 5]. The average duration of this
radiological abnormality is 7–9 weeks, although few stud-
ies are available on this topic [5]. Nevertheless, this sign
is not systematically observed, which allows other
hypotheses. Mark et al. [5] have suggested that a benign
viral or an idiopathic inflammatory neuropathy can be
implicated because the contrast enhancement of the nerve
could be observed in such cases.
In the literature, the research for an alternative cause is
particularly heterogeneous, as observed in our work.
Because numerous diseases can mimic OM, such as vas-
cular aneurysm, myasthenia gravis, oculomotor nerve
schwannoma, pituitary apoplexy, Tolosa-Hunt syndrome,
mucomycosis and ischaemic or idiopathic cranial palsy,
paraclinical examinations are always required [4, 5]. In
published cases as in ours, biological blood tests are
sometimes carried out to rule out diabetes mellitus, myas-
thenia gravis or an inflammatory disease [3, 4, 11]. To
date, there is no consensus on the tests and ICHD II does
not recommend making such biological investigations and
gives no guidelines for blood tests. As for clinical descrip-
tion, future recommendation would propose the type and
number of biological blood tests necessary for OM diag-
nosis. On the contrary, ICHD II recommends ruling out by
appropriate investigation parasellar, orbital fissure or pos-
terior fossa lesion. The choice of radiological examination
is also not specified, allowing clinicians to do CT-scan or
MRI. This heterogeneity is well represented in our obser-
vation, coming from several six different centres. Because
of the presence of a possible contrast enhancement of the
cranial nerve and the greater sensitivity of MRI, this radi-
ological exploration should be systematically proposed to
exclude the main differential diagnosis in the future [3, 6,
12, 13].
Our retrospective study emphasises the difficulties of
making an OM diagnosis and demonstrates the hetero-
geneity of the paraclinical tests performed for giving such
a diagnosis. Although clinical signs are now well
described in ICHD-II, diagnosis remains difficult in clini-
cal practice because numerous diseases can produce
migraine and oculomotor nerve palsy. This work suggests
that the future IHS guidelines insist on a biological blood
test as well as the type of cranial imagery necessary for
OM diagnosis. Cranial MRI with contrast appears funda-
mental not only to exclude an alternative aetiology but
also to improve the knowledge of this rare disease.
Another proposition should be to have the possibility to
identify a case as probable OM when all criteria are not
present, in order to follow the evolution of this rare dis-
ease.
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